1.The study on super selective hepatic artery embolization for effects of hepatic cyst volume and liver function of symptomatic patients with polycystic liver
China Medical Equipment 2016;13(8):57-59,60
Objective:To investigate the super selective transhepatic arterial embolization (TAE) for effects of cyst volume and liver function in patients with symptomatic polycystic liver disease (PLD), and provide a reliable basis for clinical diagnosis and treatment. Methods: 14 cases of symptomatic patients with PLD were selected from October 2014 to October 2015 in our hospital using super selective hepatic arterial embolization. The upper abdomen was performed CT scan one year after surgery, and the volume of patients with liver cyst was tested. We observed the changes of total volume of liver before TAE and postoperative kidney function, adverse reactions, and the improvements after four months’ follow-up.Results: The angiography for the 14 patients showed liver volume increased in different degrees. It also showed that blood supply was mainly hepatic artery wall branch. There were different sizes of liver round unstained area. There was consistent between CT examination and unstained area in polycystic liver swollen area. The difference of the total volume of the liver cyst was statistically significant in 14 cases of the patients with PLD before TAE treatment and after 12 months’ treatment (t=2.8627,P<0.05). 14 cases of the patients with PLD after TAE before treatment and after 1 week’s laboratory tests, the difference was not statistically significant among AST, ALT, ALB and TBIL (t=0.0441,t=0.3316,t=0.0722,t=1.9855;P>0.05). Compared with the preoperative, there was little effect on liver function by TAE. After 3 to 12 months, symptoms gradually improved and physical rating increased. The improvement rate was 100% after 12 months and the physical score was from 90 to 100 points. The embolism syndrome in 14 cases of patients gradually disappeared after 1 to 5 days, and five days later the symptoms disappeared. Conclusions: There is a significant effect for symptomatic polycystic liver patients with TAE. It can improve efficacy and reduce patient suffering with a low recurrence rate. It is worthy of clinical application.
2.Clinical value assessment of Prefabricated-Posts in oral cavity repair
Hu ZHENG ; Jianqing GUO ; Xianfang ZHANG
China Medical Equipment 2013;(12):61-63
Objective:The clinical value of used in oral cavity repair were summarized to guide clinical practice. Methods:Retrospective analysis the clinical information of 144 cases(prefabricated posts:86 cases and metal posts:58 cases) who received oral cavity repair in our hospital between January 2010 and January 2012. Discuss the applications and clinical effects. Results:After 1 to 2 ears of follow-up, into a successful repair success rate of fiber post and metal post(93.02%v.s.79.31%, P=0.015), advance into a fiber post success rate is significantly higher than metal post, Repair the cause of the failure of the two groups, however, fall off and fracture was statistically difference(x2=5.51, P<0.019), the fiber pile of biomechanics is better than metal post, loss is the main reason for the advance into the fiber pile repair failure. Conclusions:As a new material in the oral cavity repair, prefabricated posts has been widely used and is worthy of further promotion.
3.Observation on clinical efficacy of entecavir combined with danshen drip-ping pill for the treatment of chronic hepatitis B with hepatic fibrosis
China Modern Doctor 2014;(20):49-51
Objective To investigate the clinical efficacy of entecavir combined with danshen dripping pill for the treatment of chronic hepatitis B with hepatic fibrosis. Methods A total of 46 cases of chronic hepatitis B with hepatic fibrosis in our hospital were randomly divided into control group and observation group. The control group were treated with entecavir. The observation group were treated with entecavir combined with danshen dripping pill.The HBV-DNA negative rate, serum fibrosis markers (Serum HA,LN,PCⅢ,CⅣ) before and after treatment of two groups were com-pared. Results The HBV-DNA negative rate of observation group was 95.7%, which was significantly higher than 65.2% of control group (P<0.05). The serum fibrosis markers of two groups before treatment had no significant differ-ence(P>0.05). Serum HA,LN,PCⅢ,CⅣlevels of observation group after treatment were significantly lower than control group(P<0.05). Conclusion Entecavir combined with danshen dripping pill treatment for chronic hepatitis B with hep-atic fibrosis has exact effect. It can effectively reduce inflammatory activity,improve microcirculation and slow fibrosis down. It’s worthy of clinical widely used.